Subsequently, it induced an antitumor immune microenvironment, promoted the Th1 type helper T‐cell immune response, and the maturation of DCs within the tumor, thereby significantly enhancing the treatment response of mice to the CTLA‐4 antibody [122]. The gene discussed is CTLA4; the disease is neoplasm.